A) Probably effective: Some CAM treatments (I estimate about 5% of the total) are now supported by solid or at least encouraging evidence. For example, nearly 40 clinical trials of St. John's wort have been published, and the totality of this evidence strongly suggests effectiveness of this herbal in the treatment of mild-to-moderate depression (Ernst et al., 2006) . Other treatments that are backed by reasonably convincing evidence are listed in Table 1 . B) Probably ineffective: Several CAM treatments (I estimate about 20% of the total) seem to be ineffective. Science is, of course, a poor tool for proving a negative but, if the majority of the reliable evidence does not indicate any specific effects, it seems reasonable to assume (until data to the contrary emerge) that the treatment in question is not effective. Probably ineffective CAM approaches include homeopathy, Bach Flower Remedies, iridology, and applied kinesiology (Ernst et al., 2006) . C) Not sufficiently investigated: The vast majority of CAM (I estimate about 75% of the total) has not been researched in sufficient detail to be sure either way (Ernst et al., 2006) . In these cases, most CAM enthusiasts seem to think ''it might work, so let's use it.'' This attitude, however, is in danger of promoting a double standard. In medicine, regardless of whether we call in conventional or CAM, the cautionary principle demands proof that a treatment generates more good than harm before using it in routine health care.
4. Despite many affirmations to the contrary, there is currently little convincing evidence to suggest that the wholesale integration of CAM into routine healthcare would save money (Canter, Thompson Coon, & Ernst, 2005) . Many attempts to convince us otherwise have been published (e.g., Smallwood, 2005) . They do, however, not withstand critical evaluation and seem to be more the result of wishful thinking than of scientific analysis. 5. Conflicts of interest are common in CAM. For instance, a patient guide published in the United Kingdom by the ''Prince of Wales's Foundation for Integrated Health'' and sponsored by tax payer's money, openly promotes unproven and disproven treatments without providing even the most basic evidential details (The Prince of Wales's Foundation for Integrated Health, 2005)-a situation that is unthinkable in any clinical field. Other conflicts of interest range from the quasi-religious beliefs of CAM proponents to the financial interests of ''health writers,'' manufacturers, and CAM practitioners. 6. The current, widespread lack of regulation of CAM in many parts of the world can put patients at risk. For instance, the herbal antidepressant St. John's wort is widely available in pharmacies, health food shops, supermarkets, and even petrol stations. Because of its potential to cause herb-drug interactions (Ernst et al., 2006) , and because depression is a life-threatening condition, this unlimited availability has the potential to cause harm. 7. Vis-a-vis the plethora of important unanswered questions, the amount of research funding currently invested into CAM is deplorable (Wider & Ernst, 2003) . In the United Kingdom, the research funds have been very close to zero for many years. The United States and German authorities have spent hundreds of millions on CAM research-but even these seemingly impressive amounts of money look meek when expressed as percentages of total medical research budgets: they are well below the 10% margins. If we also consider private funding sources, for example, the pharmaceutical industry, the imbalance becomes even more obvious. The political will to change this situation seems to be absent both in the United Kingdom and, as far as I can see, elsewhere.
In conclusion, CAM has become a major public health issue. The sooner we resolve the numerous uncertainties, the better for us all. To make progress, we require more research, reliable information about the existing data, transparency, effective regulation that protects the public, and sufficient funds to do all this.
